HEADER TRANSFERASE 29-OCT-04 1XW5 TITLE HUMAN GLUTATHIONE S-TRANSFERASE M2-2 (E.C.2.5.1.18)COMPLEXED WITH TITLE 2 GLUTATHIONE, MONOCLINIC CRYSTAL FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE MU 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSTM2-2, GST CLASS-MU 2; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTM2, GST4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET3A; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A-HGSTM2 KEYWDS TRANSFERASE, GLUTATHIONE, CONJUGATION, DETOXIFICATION, CYTOSOLIC, KEYWDS 2 DIMER, ACTIVE SITE EXPDTA X-RAY DIFFRACTION AUTHOR L.N.PATSKOVSKA,Y.V.PATSKOVSKY,S.C.ALMO,I.LISTOWSKY REVDAT 5 23-AUG-23 1XW5 1 REMARK REVDAT 4 11-OCT-17 1XW5 1 REMARK REVDAT 3 24-FEB-09 1XW5 1 VERSN REVDAT 2 15-FEB-05 1XW5 1 TITLE REVDAT 1 30-NOV-04 1XW5 0 JRNL AUTH Y.PATSKOVSKY,L.N.PATSKOVSKA,S.C.ALMO,I.LISTOWSKY JRNL TITL STRUCTURAL PERTURBATION OF THE ACTIVE SITE OF HUMAN JRNL TITL 2 GLUTATHIONE-S-TRANSFERASE M2-2 UPON LIGAND BINDING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.N.PATSKOVSKA,A.A.FEDOROV,Y.V.PATSKOVSKY,S.C.ALMO, REMARK 1 AUTH 2 I.LISTOWSKY REMARK 1 TITL EXPRESSION, CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS REMARK 1 TITL 2 OF LIGAND-FREE HUMAN GLUTATHIONE S-TRANSFERASE M2-2 REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 458 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.RAGHUNATHAN,R.J.CHANDROSS,R.H.KRETSINGER,T.J.ALLISON, REMARK 1 AUTH 2 C.J.PENINGTON,G.S.RULE REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN CLASS MU GLUTATHIONE TRANSFERASE REMARK 1 TITL 2 GSTM2-2. EFFECTS OF LATTICE PACKING ON CONFORMATIONAL REMARK 1 TITL 3 HETEROGENEITY REMARK 1 REF J.MOL.BIOL. V. 238 815 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH W.R.VORACHEK,W.R.PEARSON,G.S.RULE REMARK 1 TITL CLONING, EXPRESSION, AND CHARACTERIZATION OF A CLASS-MU REMARK 1 TITL 2 GLUTATHIONE TRANSFERASE FROM HUMAN MUSCLE, THE PRODUCT OF REMARK 1 TITL 3 THE GST4 LOCUS REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 88 4443 1991 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.6 REMARK 3 NUMBER OF REFLECTIONS : 38283 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1160 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3491 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE : 0.3110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 99 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.031 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3614 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 461 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.41000 REMARK 3 B22 (A**2) : 4.85000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.29000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.240 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.860 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.290 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.590 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.640 ; 4.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 25.41 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : GSHPARAM.PEP REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : GSHTOP.PEP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XW5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1000030834. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38664 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.3 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : 0.06200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 43.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.01700 REMARK 200 R SYM FOR SHELL (I) : 0.01900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 2GTU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG4000, PH 6.50, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.89500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A HOMODIMER, THE ASSYMETRIC UNIT REMARK 300 CONTAINS HOMODIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 71 106.58 75.18 REMARK 500 PRO B 57 122.31 -36.77 REMARK 500 GLN B 71 103.54 79.67 REMARK 500 LEU B 85 41.09 -109.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 471 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 472 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GTU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LIGAND-FREE HUMAN GLUTATHIONE-S-TRANSFERASE M2- REMARK 900 2 REMARK 900 RELATED ID: 1HNA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE-S-TRANSFERASE M2-2 REMARK 900 (TRP214PHE MUTANT) DBREF 1XW5 A 1 217 UNP P28161 GSTM2_HUMAN 1 217 DBREF 1XW5 B 1 217 UNP P28161 GSTM2_HUMAN 1 217 SEQRES 1 A 217 PRO MET THR LEU GLY TYR TRP ASN ILE ARG GLY LEU ALA SEQRES 2 A 217 HIS SER ILE ARG LEU LEU LEU GLU TYR THR ASP SER SER SEQRES 3 A 217 TYR GLU GLU LYS LYS TYR THR MET GLY ASP ALA PRO ASP SEQRES 4 A 217 TYR ASP ARG SER GLN TRP LEU ASN GLU LYS PHE LYS LEU SEQRES 5 A 217 GLY LEU ASP PHE PRO ASN LEU PRO TYR LEU ILE ASP GLY SEQRES 6 A 217 THR HIS LYS ILE THR GLN SER ASN ALA ILE LEU ARG TYR SEQRES 7 A 217 ILE ALA ARG LYS HIS ASN LEU CYS GLY GLU SER GLU LYS SEQRES 8 A 217 GLU GLN ILE ARG GLU ASP ILE LEU GLU ASN GLN PHE MET SEQRES 9 A 217 ASP SER ARG MET GLN LEU ALA LYS LEU CYS TYR ASP PRO SEQRES 10 A 217 ASP PHE GLU LYS LEU LYS PRO GLU TYR LEU GLN ALA LEU SEQRES 11 A 217 PRO GLU MET LEU LYS LEU TYR SER GLN PHE LEU GLY LYS SEQRES 12 A 217 GLN PRO TRP PHE LEU GLY ASP LYS ILE THR PHE VAL ASP SEQRES 13 A 217 PHE ILE ALA TYR ASP VAL LEU GLU ARG ASN GLN VAL PHE SEQRES 14 A 217 GLU PRO SER CYS LEU ASP ALA PHE PRO ASN LEU LYS ASP SEQRES 15 A 217 PHE ILE SER ARG PHE GLU GLY LEU GLU LYS ILE SER ALA SEQRES 16 A 217 TYR MET LYS SER SER ARG PHE LEU PRO ARG PRO VAL PHE SEQRES 17 A 217 THR LYS MET ALA VAL TRP GLY ASN LYS SEQRES 1 B 217 PRO MET THR LEU GLY TYR TRP ASN ILE ARG GLY LEU ALA SEQRES 2 B 217 HIS SER ILE ARG LEU LEU LEU GLU TYR THR ASP SER SER SEQRES 3 B 217 TYR GLU GLU LYS LYS TYR THR MET GLY ASP ALA PRO ASP SEQRES 4 B 217 TYR ASP ARG SER GLN TRP LEU ASN GLU LYS PHE LYS LEU SEQRES 5 B 217 GLY LEU ASP PHE PRO ASN LEU PRO TYR LEU ILE ASP GLY SEQRES 6 B 217 THR HIS LYS ILE THR GLN SER ASN ALA ILE LEU ARG TYR SEQRES 7 B 217 ILE ALA ARG LYS HIS ASN LEU CYS GLY GLU SER GLU LYS SEQRES 8 B 217 GLU GLN ILE ARG GLU ASP ILE LEU GLU ASN GLN PHE MET SEQRES 9 B 217 ASP SER ARG MET GLN LEU ALA LYS LEU CYS TYR ASP PRO SEQRES 10 B 217 ASP PHE GLU LYS LEU LYS PRO GLU TYR LEU GLN ALA LEU SEQRES 11 B 217 PRO GLU MET LEU LYS LEU TYR SER GLN PHE LEU GLY LYS SEQRES 12 B 217 GLN PRO TRP PHE LEU GLY ASP LYS ILE THR PHE VAL ASP SEQRES 13 B 217 PHE ILE ALA TYR ASP VAL LEU GLU ARG ASN GLN VAL PHE SEQRES 14 B 217 GLU PRO SER CYS LEU ASP ALA PHE PRO ASN LEU LYS ASP SEQRES 15 B 217 PHE ILE SER ARG PHE GLU GLY LEU GLU LYS ILE SER ALA SEQRES 16 B 217 TYR MET LYS SER SER ARG PHE LEU PRO ARG PRO VAL PHE SEQRES 17 B 217 THR LYS MET ALA VAL TRP GLY ASN LYS HET GSH A 471 20 HET GSH B 472 20 HETNAM GSH GLUTATHIONE FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 5 HOH *461(H2 O) HELIX 1 1 ARG A 10 LEU A 12 5 3 HELIX 2 2 ALA A 13 THR A 23 1 11 HELIX 3 3 ARG A 42 ASN A 47 1 6 HELIX 4 4 GLU A 48 LEU A 52 5 5 HELIX 5 5 GLN A 71 LYS A 82 1 12 HELIX 6 6 SER A 89 TYR A 115 1 27 HELIX 7 7 ASP A 118 GLY A 142 1 25 HELIX 8 8 THR A 153 GLU A 170 1 18 HELIX 9 9 PHE A 177 GLY A 189 1 13 HELIX 10 10 LEU A 190 LYS A 198 1 9 HELIX 11 11 ARG B 10 LEU B 12 5 3 HELIX 12 12 ALA B 13 THR B 23 1 11 HELIX 13 13 ARG B 42 ASN B 47 1 6 HELIX 14 14 GLU B 48 LEU B 52 5 5 HELIX 15 15 GLN B 71 HIS B 83 1 13 HELIX 16 16 SER B 89 TYR B 115 1 27 HELIX 17 17 ASP B 118 GLY B 142 1 25 HELIX 18 18 THR B 153 GLU B 170 1 18 HELIX 19 19 PHE B 177 LEU B 190 1 14 HELIX 20 20 LEU B 190 SER B 199 1 10 SHEET 1 A 4 TYR A 27 TYR A 32 0 SHEET 2 A 4 MET A 2 TRP A 7 1 N LEU A 4 O GLU A 28 SHEET 3 A 4 TYR A 61 ASP A 64 -1 O ILE A 63 N THR A 3 SHEET 4 A 4 HIS A 67 THR A 70 -1 O ILE A 69 N LEU A 62 SHEET 1 B 4 TYR B 27 TYR B 32 0 SHEET 2 B 4 MET B 2 TRP B 7 1 N MET B 2 O GLU B 28 SHEET 3 B 4 TYR B 61 ASP B 64 -1 O ILE B 63 N THR B 3 SHEET 4 B 4 HIS B 67 THR B 70 -1 O HIS B 67 N ASP B 64 CISPEP 1 ALA A 37 PRO A 38 0 -0.16 CISPEP 2 LEU A 59 PRO A 60 0 0.11 CISPEP 3 ARG A 205 PRO A 206 0 -0.39 CISPEP 4 ALA B 37 PRO B 38 0 0.05 CISPEP 5 LEU B 59 PRO B 60 0 0.10 CISPEP 6 ARG B 205 PRO B 206 0 -0.25 SITE 1 AC1 18 TYR A 6 TRP A 7 LEU A 12 ARG A 42 SITE 2 AC1 18 TRP A 45 LYS A 49 ASN A 58 LEU A 59 SITE 3 AC1 18 PRO A 60 GLN A 71 SER A 72 HOH A 482 SITE 4 AC1 18 HOH A 533 HOH A 548 HOH A 558 HOH A 575 SITE 5 AC1 18 HOH A 693 ASP B 105 SITE 1 AC2 19 ASP A 105 TYR B 6 TRP B 7 LEU B 12 SITE 2 AC2 19 ARG B 42 TRP B 45 LYS B 49 ASN B 58 SITE 3 AC2 19 LEU B 59 PRO B 60 GLN B 71 SER B 72 SITE 4 AC2 19 HOH B 477 HOH B 492 HOH B 504 HOH B 623 SITE 5 AC2 19 HOH B 664 HOH B 665 HOH B 667 CRYST1 51.200 49.790 92.040 90.00 94.27 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019531 0.000000 0.001458 0.00000 SCALE2 0.000000 0.020084 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010895 0.00000